These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 926579)

  • 1. [Effect of oral contraceptives on the blood lipid level].
    Zhemerikina EV; Afonina IP; Zykova VP; Khomasuridze AG
    Kardiologiia; 1977 Sep; 17(9):104-8. PubMed ID: 926579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive estrogen and plasma lipid levels.
    Hedlin A; Kuksis A; Geher K
    Obstet Gynecol; 1978 Oct; 52(4):430-5. PubMed ID: 714324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a progestogen and a sequential type oral contraceptive on plasma vitamin A, vitamin E, cholesterol and triglycerides.
    Yeung DL; Chan PL
    Am J Clin Nutr; 1975 Jul; 28(7):686-91. PubMed ID: 1146718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term effect of hormonal contraceptives on the behavior of serum lipids].
    Klinger G; Carol W; Hoppe H; Müller B; Bonow A
    Zentralbl Gynakol; 1977; 99(5):271-6. PubMed ID: 194435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins.
    Bradley DD; Wingerd J; Petitti DB; Krauss RM; Ramcharan S
    N Engl J Med; 1978 Jul; 299(1):17-20. PubMed ID: 207983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The metabolic effects of contraception with oestrogen-progestogen products (author's transl)].
    Heim J
    J Gynecol Obstet Biol Reprod (Paris); 1979; 8(8):745-9. PubMed ID: 233376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.
    Briggs MH
    J Reprod Med; 1983 Jan; 28(1 Suppl):92-9. PubMed ID: 6403706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a once-a-week steroid contraceptive (R2323) on lipid and carbohydrate metabolism in women during three months of use.
    Spellacy WN; Buhi WC; Dumbaugh VA; Birk SA
    Fertil Steril; 1978 Sep; 30(3):289-92. PubMed ID: 710600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some effects of an oral contraceptive on dietary carbohydrate-lipid interrelations in the baboon.
    Stovin V; Macdonald I
    Proc Nutr Soc; 1975 Sep; 34(2):55A-56A. PubMed ID: 810806
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical basis for the selection of oral contraceptives.
    Briggs MH
    Int J Gynaecol Obstet; 1978-1979; 16(6):509-17. PubMed ID: 39819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ultrastructure of endometrium during low-dose gestagenic anticonception (author's transl)].
    Houdek J; Pelák Z; Vacek Z
    Cesk Gynekol; 1977 Feb; 42(1):26-7. PubMed ID: 844109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
    Walsh BW; Sacks FM
    J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of hyperprolactinemia during oral contraceptive therapy.
    Reyniak JV; Wenof M; Aubert JM; Stangel JJ
    Obstet Gynecol; 1980 Jan; 55(1):8-11. PubMed ID: 7352067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and physiological variables.
    Ostrander LD; Lamphiear DE; Block WD; Williams GW; Carmen WJ
    JAMA; 1980 Aug; 244(7):677-9. PubMed ID: 6993716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proceedings: Oral contraceptives and lipid metabolism].
    Kaffarnik H; Karschnia R
    Arch Gynakol; 1973 Sep; 214(1):263-4. PubMed ID: 4801446
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral contraceptives and lipoprotein metabolism.
    Tikkanen MJ; Nikkilä EA
    J Reprod Med; 1986 Sep; 31(9 Suppl):898-905. PubMed ID: 3772909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid changes during contraceptive administration in obese women: relation to serum insulin levels.
    Gershberg H; Hulse M; Galler M
    J Clin Endocrinol Metab; 1976 Oct; 43(4):861-5. PubMed ID: 977725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.